PSFL2915 is a selective, orally active P2X receptor inhibitor with oral effectiveness, with an IC 50 of 0.319 μM for human P2X3 , 0.261 μM for rat P2X2/3 , and 13.3 μM for human P2X2 . PSFL2915 exhibits ~42-fold selectivity over human P2X2 . PSFL2915 can be used for the research of chronic cough.
Products | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Pulmonary Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > P2X Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.